Related Experiment Video

Updated: Jul 19, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

[Antibiotherapy for acute CAP in adults]

E Denes1

  • 1Service de maladies infectieuses et tropicales, CHU Dupuytren, 2, avenue Martin-Luther-King, 87042 Limoges cedex, France. eric.denes@unilim.fr

Medecine Et Maladies Infectieuses
|November 10, 2006
PubMed

Insights

Community acquired pneumonia requires updated antibiotic guidance due to evolving bacterial resistance. New antibiotics like fluoroquinolones show effectiveness, but resistance monitoring is crucial for optimal treatment.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Context:

  • Community-acquired pneumonia (CAP) is a common infection with changing bacterial resistance patterns.
  • Emerging antibiotic resistance necessitates updated treatment guidelines for CAP.
  • New antibiotics offer alternative treatment options for CAP.

Purpose:

  • To review the current epidemiology of pneumonia and evolving bacterial resistance.
  • To assess the efficacy of new antibiotics, including fluoroquinolones, for CAP treatment.
  • To provide an updated perspective on appropriate antibiotic use in CAP.

Summary:

  • Review covers pneumonia epidemiology, bacterial resistance trends, and new antibiotics (levofloxacin, moxifloxacin, telithromycin, pristinamycin).
  • Fluoroquinolones are effective against common pneumonia pathogens, though resistance detection can be challenging.
  • Moxifloxacin may offer superior bacteriological and pharmacological advantages over levofloxacin in some contexts.

Impact:

  • Informs clinical practice regarding antibiotic selection for CAP.
  • Highlights the need for vigilant monitoring of fluoroquinolone resistance.
  • Supports evidence-based guidelines for managing CAP in the face of antimicrobial resistance.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...